Involvement of the PI3K/Nrf2 Pathway in Arsenic-Induced Endocrine and Thyroid Toxicity in Rats.

J Appl Toxicol

School of Public Health, Key Laboratory of Special Environmental and Health Research, Xinjiang Medical University, Urumqi, China.

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Humans' exposure to arsenic (As) has been associated with the development of various diseases. Some health effects may be mediated by arsenic-induced toxicity to the thyroid and endocrine systems, but its underlying mechanisms remain unclear. The overall aim of our study was focused on using sodium arsenite (NaAsO)-exposed rats to investigate the involvement of the phosphatidylinositol 3-kinase (PI3K) and transcription factor NF-E2-related factor 2 (Nrf2) pathways in toxicity to the thyroid and endocrine systems. In our in vitro study, exposure of thyroid cells (a thyroid follicular epithelial cell line) to 0, 0.4, 0.8, and 3.2 μM. NaAsO caused reduced triiodothyronine (T3) and thyroxine (T4) levels, significantly increased estrogen receptor alpha (ERα) and thyroid hormone receptor alpha (TRα) mRNA levels, reduced Kelch-like epichlorohydrin-associated protein-1 (Keap1) and AKT serine (AKT) mRNA expression, and increased Nrf2 and PI3K mRNA expression (p < 0.05). In the in vivo study, Wistar rats were treated with 0, 0.8, 4.0, and 20.0 mg/kg/d of NaAsO for 20 weeks. The exposure caused dose-dependent histopathological changes in the thyroid, a significant increase in serum estradiol (E2), accompanied by alterations in thyroid hormone metabolism, as evidenced by decreased triiodothyronine (TG), T3, and T4 (p < 0.05). Additionally, mRNA expression levels of ERα and TRα were significantly altered in the thyroid tissues. Keap1, Nrf2, PI3K, and AKT mRNA expression levels were increased (p < 0.05). Specifically, exposure to NaAsO disrupted normal thyroid functions by regulating the PI3K/Nrf2 pathway. Our findings indicate that NaAsO exposure induced cytotoxicity and disrupted estrogen production both in vivo and in vitro investigations, leading to thyroid dysfunction through altered expression of the PI3K/Nrf2 pathway. These findings highlight the complex mechanisms through which arsenic disrupted thyroid function and endocrine homeostasis.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jat.4905DOI Listing

Publication Analysis

Top Keywords

toxicity thyroid
8
thyroid endocrine
8
endocrine systems
8
receptor alpha
8
mrna expression
8
thyroid
6
involvement pi3k/nrf2
4
pi3k/nrf2 pathway
4
pathway arsenic-induced
4
arsenic-induced endocrine
4

Similar Publications

Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of the fungal biomass from species strain as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF as the frozen form of the sp. str.

View Article and Find Full Text PDF

Involvement of the PI3K/Nrf2 Pathway in Arsenic-Induced Endocrine and Thyroid Toxicity in Rats.

J Appl Toxicol

September 2025

School of Public Health, Key Laboratory of Special Environmental and Health Research, Xinjiang Medical University, Urumqi, China.

Humans' exposure to arsenic (As) has been associated with the development of various diseases. Some health effects may be mediated by arsenic-induced toxicity to the thyroid and endocrine systems, but its underlying mechanisms remain unclear. The overall aim of our study was focused on using sodium arsenite (NaAsO)-exposed rats to investigate the involvement of the phosphatidylinositol 3-kinase (PI3K) and transcription factor NF-E2-related factor 2 (Nrf2) pathways in toxicity to the thyroid and endocrine systems.

View Article and Find Full Text PDF

Background And Objective: Radioiodine-refractory differentiated thyroid cancer (RAIR-DTC) remains challenging to treat due to a lack of effective therapies. This study aimed to evaluate the efficacy and safety of combining anlotinib with iodine-125 (I) seed implantation in patients with RAIR-DTC.

Methods And Materials: We retrospectively compared three treatment groups in 52 patients with advanced RAIR-DTC: anlotinib monotherapy (Group A, = 14), I seed brachytherapy monotherapy (Group B, = 25), and combined therapy (Group C, = 13).

View Article and Find Full Text PDF

Endocrine Adverse Events of Immune Checkpoint Inhibitors: A Comprehensive Review.

Indian J Endocrinol Metab

August 2025

Department of Endocrinology, Diabetes and Metabolism, Christian Medical College Vellore, Vellore, Tamil Nadu, India.

Immune checkpoint inhibitors (ICIs) have revolutionised cancer therapy by enhancing T-cell-mediated tumour eradication. However, their use is associated with immune-related adverse events, with endocrinopathies being the most common. Thyroid dysfunction, hypophysitis, primary adrenal insufficiency (PAI), and insulin-dependent diabetes mellitus are well-documented complications.

View Article and Find Full Text PDF

A comprehensive review of existing toxicity and human exposure data for the ultraviolet filter avobenzone (butyl methoxydibenzoylmethane) was conducted to assess its safety as currently used in over-the-counter sunscreen formulations. Avobenzone has a suitable safety profile without any clear markers of toxicity or endpoints of concern. There are sufficient clinical studies and and toxicity studies in animal models to assess avobenzone's pharmacokinetics, pharmacodynamics, and potential toxicological properties, supportive of its long history of safe use.

View Article and Find Full Text PDF